Stockreporter Announces Investment Opinion on TTR Technologies
Stockreporter.de begins coverage of TTR Technologies, Inc. (TTRE) with a Strong Buy recommendation and a year-end 2000 price target of $12 to $13 per share.
NEW YORK--(BUSINESS WIRE)--Jan. 21, 2000-- TTR Technologies, Inc. (OTC BB: TTRE) has received a strong buy recommendation from Stockreporter, a leading European financial Internet publication located at www.stockreporter.de. Stockreporter specializes in the coverage of micro-cap stocks and undervalued OTC and BB companies. The successful Stockreporter team is one of the first independent analysts to begin coverage and release an investment opinion on this fast growing high technology company. TTRE is currently trading in the $8 to $9 range. Based on the Company's expected growth rate, agreements in hand, and a PE ratio of 30x earnings, Stockreporter is beginning coverage of TTRE with a target price of $12.50 per share by the year-end 2000 and $35.00 per share for the year 2001.
``We are extremely pleased to initiate coverage of TTR Technologies, Inc. with a Strong Buy recommendation for investors seeking aggressive long-term growth potential,' commented Torsten Prochnow from Stockreporter. ``The Company's first product, DiscGuard(TM), is designed to prevent unauthorized CD-ROMS from operating as intended. TTR's copy protection technology offers software publishers an effective solution to protect their products distributed on CD-ROMs and DVDs, while offering convenience and cost effectiveness to the software publisher and end-user. We believe that the Company's DiscGuard(TM) and MusicGuard(TM) products are technologically superior, and will be readily accepted by music and software publishers to increase their profits by protecting their applications from unauthorized copying.'
The complete TTR Technologies report issued by Stockreporter is available in English and German and can be accessed at www.stockreporter.de.
NOTICE
All Stockreporter recommendations are made on an unsolicited basis. The complete recommendation and additional information (e.g. forthcoming interviews with the CEO and the President) can be accessed on Stockreporter's website at www.stockreporter.de, which is going to be the No. 1 micro-cap and OTC BB site in Europe; especially in Germany. The site is completely available in both the German and English languages. Stockreporter meticulously and independently selects the companies that are candidates for a buy recommendation and which are featured on the Stockreporter website. Stockreporter does not receive a fee for any of its buy recommendations and does not charge a fee for its buy recommendations to the companies concerned. In certain cases, Stockreporter will only accept a basic reimbursement of costs (e.g. American-English Translation Services, Business Wire fees, administrative expenses, etc.) to cover in these cases the higher costs.
Any Stockreporter micro-cap recommendation still includes a high degree of risk and is at the investor's individual and own risk. Many Stockreporter recommendations contain forms of ``forward-looking statements' that are based on the company's beliefs as well as assumptions made by information currently available to Stockreporter and to the general public. Such statements are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results will vary materially from those anticipated, estimated, or projected and the variations may be material. Therefore, no claim for any kind of warranty can and will be accepted by Stockreporter. Moreover, the team of Stockreporter wants to stress once again that all our buy recommendations are based on subjective assessments that have been made exclusively on the basis of facts being known to the general public.
If you have any further questions regarding this buy recommendation or any other inquiry or suggestion, please do not hesitate to contact Stockreporter at any time. We are very interested in maintaining close contact with both institutional and private investors as well as OTC and BB companies.
--------------------------------------------------------------------------------
Contact:
Mr. Torsten Prochnow
(+49-172-4031383)
contact@stockreporter.de
www.stockreporter.de |
